Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”

Hanne Bruhn* (Corresponding Author), Annie S. Anderson, Amy Hickman, E. Jane Macaskill, Shaun Treweek

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article, we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic, and we hope this article can help other trial teams to plan their own online events.
Original languageEnglish
Article number381
Number of pages5
JournalTrials
Volume22
Issue number1
DOIs
Publication statusPublished - 5 Jun 2021

Keywords

  • Randomised trials
  • Research transparency
  • Result dissemination
  • Trial conduct
  • Online events
  • COVID-19

Fingerprint Dive into the research topics of 'Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”'. Together they form a unique fingerprint.

Cite this